Actively Recruiting
Evidence-based Internet Cognitive-behavioral Therapy for Social Anxiety
Led by Université de Sherbrooke · Updated on 2025-05-30
252
Participants Needed
2
Research Sites
86 weeks
Total Duration
On this page
Sponsors
U
Université de Sherbrooke
Lead Sponsor
C
Canadian Institutes of Health Research (CIHR)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The objectives of the study are to 1) to translate and adapt iCBT Shyness Program to the Canadian context; 2) to examine the completion and effectiveness of the Canadian adapted, including the French translated and English iCBT Shyness Program, in improving SAD symptoms; 3) to explore barriers and facilitating factors to the program's implementation. The overall study design is a hybrid effectiveness-implementation study of a quasi-experimental parallel group trial reflecting real world pathways (recommended and self-referrals). The project will be conducted in two Canadian provinces: Quebec (Montérégie) and Ontario. Prior to implementing the iCBT Shyness Program, it will undergo an initial adaptation to the Canadian context and focus groups will be conducted with key actor groups to discuss the adaptations to the graphics, narration of the modules, and this to better reflect varying sociocultural context among Canadian French- and English-speaking populations. We will then evaluate the outcomes associated with the implementation of the program in a three-pathway parallel trial. As a last step to this trial, semi-structured interviews will be conducted with study participants and health care providers to explore facilitating factors and barriers to the implementation of the iCBT adapted program.
CONDITIONS
Official Title
Evidence-based Internet Cognitive-behavioral Therapy for Social Anxiety
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 18 years or older
- Speak and write in French or English
- Have access to the internet and a digital device
- Screen positive for social anxiety with a Social Phobia Inventory (SPIN) score above 20
You will not qualify if you...
- Self-reported severe depression symptoms (PHQ-9 score 23 or higher)
- Recent thoughts of self-harm or suicide on PHQ-9 or Beck Depression Inventory-II
- Diagnosis of schizophrenia, bipolar disorder, or active substance use problems
- Current use of benzodiazepines
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
CISSS de la Montérégie-Centre
Greenfield Park, Quebec, Canada, J4V 2G9
Actively Recruiting
2
CIUSSS de l'Estrie - CHUS
Sherbrooke, Quebec, Canada, J1H 5H3
Actively Recruiting
Research Team
H
Helen-Maria Vasiliadis, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here